We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Zoetis (ZTS - Free Report) will report quarterly earnings of $1.35 per share in its upcoming release, pointing to a year-over-year increase of 3.1%. It is anticipated that revenues will amount to $2.14 billion, exhibiting an increase of 7% compared to the year-ago quarter.
Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Bearing this in mind, let's now explore the average estimates of specific Zoetis metrics that are commonly monitored and projected by Wall Street analysts.
The average prediction of analysts places 'Revenues- Companion Animal' at $1.38 billion. The estimate indicates a change of +12.3% from the prior-year quarter.
Analysts' assessment points toward 'Revenues- Livestock' reaching $750.92 million. The estimate points to a change of -0.9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenues- Contract Manufacturing & Human Health' should arrive at $17.86 million. The estimate indicates a change of +5.1% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenues- Livestock - Swine' will likely reach $142.30 million. The estimate indicates a change of +0.2% from the prior-year quarter.
Analysts predict that the 'Revenues- Livestock - Poultry' will reach $139.75 million. The estimate suggests a change of +0.5% year over year.
Analysts forecast 'Revenues- Livestock - Sheep and other' to reach $12.77 million. The estimate indicates a change of -56% from the prior-year quarter.
Analysts expect 'Geographic Revenues- U.S.' to come in at $1.12 billion. The estimate points to a change of +11.3% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Geographic Revenues- U.S.- Livestock' of $276.12 million. The estimate suggests a change of -2.8% year over year.
According to the collective judgment of analysts, 'Geographic Revenues- International - Companion Animal' should come in at $537.23 million. The estimate points to a change of +6.6% from the year-ago quarter.
The consensus estimate for 'Geographic Revenues- International Revenue' stands at $1.01 billion. The estimate suggests a change of +3% year over year.
The consensus among analysts is that 'Geographic Revenues- International - Livestock' will reach $469.30 million. The estimate indicates a change of -1% from the prior-year quarter.
It is projected by analysts that the 'Geographic Revenues- U.S.- Companion Animal' will reach $842.48 million. The estimate indicates a change of +16.9% from the prior-year quarter.
Shares of Zoetis have experienced a change of -6.4% in the past month compared to the -2% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), ZTS is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Zoetis (ZTS - Free Report) will report quarterly earnings of $1.35 per share in its upcoming release, pointing to a year-over-year increase of 3.1%. It is anticipated that revenues will amount to $2.14 billion, exhibiting an increase of 7% compared to the year-ago quarter.
Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Bearing this in mind, let's now explore the average estimates of specific Zoetis metrics that are commonly monitored and projected by Wall Street analysts.
The average prediction of analysts places 'Revenues- Companion Animal' at $1.38 billion. The estimate indicates a change of +12.3% from the prior-year quarter.
Analysts' assessment points toward 'Revenues- Livestock' reaching $750.92 million. The estimate points to a change of -0.9% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenues- Contract Manufacturing & Human Health' should arrive at $17.86 million. The estimate indicates a change of +5.1% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenues- Livestock - Swine' will likely reach $142.30 million. The estimate indicates a change of +0.2% from the prior-year quarter.
Analysts predict that the 'Revenues- Livestock - Poultry' will reach $139.75 million. The estimate suggests a change of +0.5% year over year.
Analysts forecast 'Revenues- Livestock - Sheep and other' to reach $12.77 million. The estimate indicates a change of -56% from the prior-year quarter.
Analysts expect 'Geographic Revenues- U.S.' to come in at $1.12 billion. The estimate points to a change of +11.3% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Geographic Revenues- U.S.- Livestock' of $276.12 million. The estimate suggests a change of -2.8% year over year.
According to the collective judgment of analysts, 'Geographic Revenues- International - Companion Animal' should come in at $537.23 million. The estimate points to a change of +6.6% from the year-ago quarter.
The consensus estimate for 'Geographic Revenues- International Revenue' stands at $1.01 billion. The estimate suggests a change of +3% year over year.
The consensus among analysts is that 'Geographic Revenues- International - Livestock' will reach $469.30 million. The estimate indicates a change of -1% from the prior-year quarter.
It is projected by analysts that the 'Geographic Revenues- U.S.- Companion Animal' will reach $842.48 million. The estimate indicates a change of +16.9% from the prior-year quarter.
View all Key Company Metrics for Zoetis here>>>
Shares of Zoetis have experienced a change of -6.4% in the past month compared to the -2% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), ZTS is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>